Drug Profile
Metronidazole ointment - SLA Pharma
Alternative Names: Metronidazole 10% ointment - SLA Pharma AG; Topical metronidazole - SLA PharmaLatest Information Update: 25 Dec 2021
Price :
$50
*
At a glance
- Originator SLA Pharma
- Class Antibacterials; Antiprotozoals; Nitroimidazoles; Radiosensitisers; Skin disorder therapies; Small molecules
- Mechanism of Action
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
- Available For Licensing Yes
Highest Development Phases
- Phase III Crohn's disease
Most Recent Events
- 18 Feb 2020 SLA Pharma plans a phase II trial for Pilonidal sinus in Turkey (Topical,Ointment) (NCT04273997)
- 12 Dec 2018 SLA Pharma plans a phase II trial for Wound in Australia , (ACTRN12618002038279)
- 17 Sep 2015 Phase-III development is ongoing in USA and United Kingdom